19 related articles for article (PubMed ID: 3731104)
1. Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx.
Takagi S; Inenaga R; Oya R; Nakamura S; Ikemura K
Br J Cancer; 2006 Jun; 94(11):1580-5. PubMed ID: 16670721
[TBL] [Abstract][Full Text] [Related]
2. Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers.
Averbach AM; Stuart OA; Sugarbaker TA; Stephens AD; Fernandez-Trigo V; Shamsa F; Sugarbaker PH
Ann Surg Oncol; 1995 Jul; 2(4):325-31. PubMed ID: 7552622
[TBL] [Abstract][Full Text] [Related]
3. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.
Wolf W; Presant CA; Servis KL; el-Tahtawy A; Albright MJ; Barker PB; Ring R; Atkinson D; Ong R; King M
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):492-6. PubMed ID: 2296605
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of cisplatin in experimental regional chemotherapy.
Wile AG; Kar R; Cohen RA; Jakowatz JG; Opfell RW
Cancer; 1987 Feb; 59(4):695-700. PubMed ID: 3802029
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 5-fluorouracil following different routes of intrahepatic administration in the canine model.
Didolkar MS; Covell DG; Jackson AJ; Walker AP; Kalidindi SR
Cancer Res; 1984 Nov; 44(11):5105-9. PubMed ID: 6488170
[TBL] [Abstract][Full Text] [Related]
7. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 5-fluorouracil in rabbits in experimental regional chemotherapy.
Kar R; Cohen RA; Terem TM; Nahabedian MY; Wile AG
Cancer Res; 1986 Sep; 46(9):4491-5. PubMed ID: 3731104
[TBL] [Abstract][Full Text] [Related]
10. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview.
Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
